Despite the rally in stocks, national economies around the world remain in recession mode. Here's what your portfolio needs now. Read More
John Persinos is managing editor of Personal Finance, Utility Forecaster, and Radical Wealth Alliance. He also writes the Mind Over Markets daily stock market recap.
John has decades of experience in the technology and political realms. He's spent decades following emerging business and technology developments. From his time at Inc. and Venture magazines, to sharing breaking market news to millions of readers across Kiplinger's, Street Authority, Investing Answers, and TheStreet.com, if it's impacted investors in the past 30 years, John was there analyzing the news and interpreting the meaning for his readers. John also has experience with the inner-workings of Capitol Hill, serving as a press secretary to U.S. Rep. Byron Dorgan.
John holds undergraduate and graduate degrees from Boston University. He also completed the Davenport Fellowship in Business and Economics Reporting at the University of Missouri (Columbia).
Analyst Articles
Small- and mid-cap stocks have been outperforming the broader market. This trend is an opportunity to protect and grow your portfolio. Read More
A psychedelic compound is infecting cicadas and forcing them into weird behavior, which in turn is opening a profitable path in drug research. Read More
It’s late August and even Congress has left for vacation. But don’t get complacent in your hammock. Plenty could still go wrong for stocks. Read More
You don’t have to be born into the social elite to enjoy wealth. Here’s how to make big money, by getting a jump on the "Big Boys" of Wall Street. Read More
We spoke with a top analyst on our team about the moves investors should (and shouldn’t) make to reap market-beating gains. Read More
Marijuana and psychedelics get most of the media attention, but oft-ignored hemp is a fertile source of investment gains. Read More
Massive monetary stimulus is keeping the stock market aloft, but the long-term consequences for investors could be dire. Read More
Wall Street is enthralled by a new coronavirus vaccine rushed forward by Vladimir Putin that hasn’t been properly tested. That’s a recipe for disaster. Read More
Akin to the mainstreaming of marijuana, there’s a growing movement to legalize and commercialize LSD. We examine the surging investor interest in acid. Read More